PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video Podcast

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 1h1m. Bisher sind 150 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 6 days 4 hours 25 minutes

subscribe
share






share








 February 23, 2022  55m
 
 

George L. Bakris, MD / Joanna Hudson, PharmD, BCPS, FASN, FCCP, FNKF - Advancing the Standard of Care for Patients with Hyperkalemia: Insights and Evidence for Clinical Pharmacy Practice


Go online to PeerView.com/YVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 February 10, 2022  1h24m
 
 

Jennifer Wargo, MD, MMSc - Leveraging Neoadjuvant and Adjuvant Immunotherapy to Break Through the Outcomes Plateau, Prevent Recurrences, and Improve Curability in Early-Stage Cancers


Go online to PeerView.com/DVD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 January 12, 2022  1h29m
 
 

Robert Dreicer, MD, MS, MACP, FASCO/Pedro C. Barata, MD, MSc - Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer


Go online to PeerView.com/TGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 January 12, 2022  56m
 
 

Petros Grivas, MD, PhD - Breaking Down the Evidence in Bladder Cancer: Expert Perspectives and Practical Strategies on Immune, Targeted, and Antibody-Based Therapies


Go online to PeerView.com/RPD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 January 11, 2022  1h8m
 
 

Sumanta Kumar Pal, MD, FASCO - Selecting and Sequencing Targeted and Immunotherapy Regimens for RCC: How Will the Latest Evidence Impact Treatment Decisions for My Patients?


Go online to PeerView.com/XZJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 January 7, 2022  55m
 
 

Erik P. Sulman, MD, PhD - Implementing Synergistic Multimodal Approaches With Tumor Treating Fields to Extend Survival in Aggressive Cancers


Go online to PeerView.com/QNS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 December 9, 2021  1h8m
 
 

Suzanne Lentzsch, MD, PhD - A New Treatment Era for Light Chain Amyloidosis: Interprofessional Lessons From a Center of Excellence


Go online to PeerView.com/KKH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 31, 2021  57m
 
 

Deborah K. Armstrong, MD - The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice


Go online to PeerView.com/BDQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 27, 2021  1h29m
 
 

Vanita R. Aroda, MD - Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM


Go online to PeerView.com/KMJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 27, 2021  20m